Condition: Respiratory Tract Infections (RTI) · Mucosal Immunity · Sponsor: Desmond Tutu TB Centre
The goal of this observational study is to answer a few questions about respiratory tract infections in South African children: 1. How do children with COVID-19 and other respiratory (chest, throat, ear or nose) germs show symptoms? What signs should be looked for, and which children are more likely to get seriously ill? Are there any new germs that haven't been discovered yet? Can immune cells in saliva predict which children will get more severe disease? 2. The body's immune response (soldier- cells) in blood and saliva (spit) will be studied. 3. What is the short-term effect of COVID-19 and other respiratory viruses/ germs on the breathing (lung function) of children? 4. What is the impact of respiratory germs on the quality of life in children and their families? The investigators aim to recruit a minimum of 250 children with respiratory pathogens.
This description comes directly from the study's public registry record.
Margaret van Niekerk, Masters (Human Nutrition) · +27219389177 · mbunting@sun.ac.za
Michaile Mackriel, PhD · +27219389177 · manthony@sun.ac.za
Always discuss trial participation with your own doctor first.
| Desmond Tutu TB Centre, Tygerberg Hospital | Cape Town, Western Cape, South Africa | Recruiting |
| Desmond Tutu TB Centre | Cape Town, Western Cape, South Africa | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06902194